NCF Diagnostics & DNA Technologies

NCF Diagnostics & DNA Technologies is a premiere clinical diagnostic laboratory specializing in molecular PCR pathogen testing. With a focus on assisting healthcare providers in diagnosing pathologic illnesses and antibiotic resistance, the company's team of PhD and Masters level molecular biologists has conducted over 300,000 patient PCR tests since its establishment in 2012. NCF Diagnostics has demonstrated expertise in helping healthcare providers effectively diagnose and treat patients with viral, bacterial, or fungal infections, while also developing over 250 PCR test assays to tackle even the most challenging cases. The company's proprietary processes and techniques ensure the highest level of accuracy, quality, and efficiency in PCR testing, showcasing its commitment to patient-focused care and integrity. As a key player in the biotechnology industry, NCF Diagnostics stands as a thought-leading force in advancing clinical diagnostics and molecular testing methodologies. However, specific information about its headquarters, recent investments, and investors is currently unavailable.